Cargando…

Lipid lowering effects and safety of evolocumab in Chinese patients at very high cardiovascular risk: a single-center study

Detalles Bibliográficos
Autores principales:	Chai, Meng, Zhang, Haitao, Yang, Lixia, Liang, Jing, Han, Hongya, Liu, Xiaoli, Ma, Xiaoteng, Liu, Yan, Shi, Dongmei, Zhao, Yingxin, Liu, Yuyang, Zhou, Yujie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Clinical Observation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10309505/ https://www.ncbi.nlm.nih.gov/pubmed/37185356 http://dx.doi.org/10.1097/CM9.0000000000002399

Ejemplares similares

Sudden Fall in the Lipid-Lowering Effect of Evolocumab: The Butler Is Not Always Guilty
por: Fogacci, Federica, et al.
Publicado: (2021)

Sudden Fall in the Lipid-Lowering Effect of Evolocumab: The Butler Is Not Always Guilty
por: Fogacci, Federica, et al.
Publicado: (2021)

Effects of Evolocumab on Cardiovascular Events
por: Mikhail, Nasser
Publicado: (2017)

Cost‐Effectiveness of LDL‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
por: Gandra, Shravanthi R., et al.
Publicado: (2016)

No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab
por: Korthauer, Laura E., et al.
Publicado: (2022)

Effect of Body Mass Index on the Prognostic Value of Atherogenic Index of Plasma in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Kan, Yi, et al.
Publicado: (2023)

Evolocumab to reduce cardiovascular events: results of the (FOURIER) multinational trial
por: Shah, Syed Raza, et al.
Publicado: (2017)

Hyperuricemia and smoking in young adults suspected of coronary artery disease ≤ 35 years of age: a hospital-based observational study
por: Lv, Sai, et al.
Publicado: (2018)

Prognostic impact of the atherogenic index of plasma in type 2 diabetes mellitus patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Ma, Xiaoteng, et al.
Publicado: (2020)

Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention
por: Han, Kangning, et al.
Publicado: (2022)

Evolocumab loaded Bio-Liposomes for efficient atherosclerosis therapy
por: Li, Zhenxian, et al.
Publicado: (2023)

Low‐density lipoprotein cholesterol lowering in real‐world patients treated with evolocumab
por: Desai, Nihar R., et al.
Publicado: (2021)

Clinical Evaluation Of Evolocumab For The Treatment Of Homozygous Familial Hypercholesterolemia In Chinese Patients
por: Huang, Chin-Chou, et al.
Publicado: (2019)

Methodology and results of cost-effectiveness of LDL-C lowering with evolocumab in patients with acute myocardial infarction in China
por: Wan, Yuansheng, et al.
Publicado: (2023)

Sinus histiocytosis (Rosai-Dorfman disease) presenting with solitary cutaneous nodule: a very rare clinical entity
por: Duarte-Williamson, Emilia, et al.
Publicado: (2012)

Cost-Effectiveness Analysis of Evolocumab in Adult Patients with Atherosclerotic Cardiovascular Disease in Canada
por: Grégoire, Jean, et al.
Publicado: (2022)

Evolocumab lowers LDL-C safely and effectively when self-administered in the at-home setting
por: Dent, Ricardo, et al.
Publicado: (2016)

Presence of Mobile Tigecycline Resistance Gene tet(X4) in Clinical Klebsiella pneumoniae
por: Zhai, Weishuai, et al.
Publicado: (2022)

Retargeting the management of hypercholesterolemia – focus on evolocumab
por: Colletti, Alessandro, et al.
Publicado: (2016)

Lipid-Lowering Treatment and the Lipid Goals Attainment in Patients with a Very High Cardiovascular Risk
por: Lis, Anna, et al.
Publicado: (2023)

Lipid A Structural Divergence in Rickettsia Pathogens
por: Guillotte, Mark L., et al.
Publicado: (2021)

To Make or Take: Bacterial Lipid Homeostasis during Infection
por: Adams, Felise G., et al.
Publicado: (2021)

Effect of Presence versus Absence of Hypertension on Admission Heart Rate-Associated Cardiovascular Risk in Patients with Acute Coronary Syndrome
por: Xia, Yihua, et al.
Publicado: (2022)

Investigating Word Length Effects in Chinese Reading
por: Zang, Chuanli, et al.
Publicado: (2018)

Lower alanine aminotransferase levels are associated with increased all-cause and cardiovascular mortality in nonalcoholic fatty liver patients
por: Zheng, Jia-Rui, et al.
Publicado: (2023)

Hyperuricemia and severity of coronary artery disease: An observational study in adults 35 years of age and younger with acute coronary syndrome
por: Lv, Sai, et al.
Publicado: (2019)

Profile of evolocumab and its potential in the treatment of hyperlipidemia
por: Cicero, Arrigo FG, et al.
Publicado: (2015)

Efficacy of Evolocumab in Monogenic vs Polygenic Hypercholesterolemia
por: Lee, Timothy, et al.
Publicado: (2019)

Maculopapular Exanthema After the Second Dose of Evolocumab
por: Ghernautan, Victoria, et al.
Publicado: (2021)

Lipid A’s Structure Mediates Neisseria gonorrhoeae Fitness during Experimental Infection of Mice and Men
por: Hobbs, Marcia M., et al.
Publicado: (2013)

Observation of the effect of angiojet to treat acute lower extremity arterial embolization
por: Meng, Xiao-Hu, et al.
Publicado: (2023)

Preoperative nuclear stress testing in the very old patient population
por: Makaryus, Amgad N, et al.
Publicado: (2020)

Effects of Evolocumab Added to Moderate-Intensity Statin Therapy in Chinese Patients With Acute Coronary Syndrome: The EMSIACS Trial Study Protocol
por: Gao, Jing, et al.
Publicado: (2021)

Systematic Review and Network Meta‐Analysis on the Efficacy of Evolocumab and Other Therapies for the Management of Lipid Levels in Hyperlipidemia
por: Toth, Peter P., et al.
Publicado: (2017)

Green channel of human organ transport improved the utilization rate of Chinese citizens’ donated lungs: a single-center data analysis
por: Li, Xiao-Shan, et al.
Publicado: (2021)

Dermoscopic features of morphea and extragenital lichen sclerosus in Chinese patients
por: Wang, Yu-Kun, et al.
Publicado: (2020)

PCSK9 inhibition in the management of hyperlipidemia: focus on evolocumab
por: Blom, Dirk J, et al.
Publicado: (2016)

Influence of Renal Function on Evolocumab Exposure, Pharmacodynamics, and Safety
por: Lee, Edward, et al.
Publicado: (2019)

Atrial Fibrillation as a Possible Adverse Reaction to Evolocumab
por: Abdelmaseih, Ramy, et al.
Publicado: (2021)

Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant
por: Cocherie, Théophile, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_relp60fjo98i6t49952lheo14t